Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 2
1972 3
1973 3
1974 2
1975 5
1976 1
1977 3
1978 2
1979 2
1980 5
1981 3
1982 8
1983 6
1984 6
1985 7
1986 8
1987 7
1988 24
1989 18
1990 7
1991 8
1992 14
1993 8
1994 13
1995 9
1996 8
1997 12
1998 6
1999 8
2000 11
2001 16
2002 6
2003 10
2004 22
2005 28
2006 38
2007 26
2008 38
2009 33
2010 28
2011 36
2012 57
2013 75
2014 82
2015 63
2016 63
2017 52
2018 58
2019 49
2020 71
2021 67
2022 66
2023 77
2024 45

Text availability

Article attribute

Article type

Publication date

Search Results

1,206 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. Among authors: bansal mb. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Harrison SA, Bashir MR, Guy CD, Zhou R, Moylan CA, Frias JP, Alkhouri N, Bansal MB, Baum S, Neuschwander-Tetri BA, Taub R, Moussa SE. Harrison SA, et al. Among authors: bansal mb. Lancet. 2019 Nov 30;394(10213):2012-2024. doi: 10.1016/S0140-6736(19)32517-6. Epub 2019 Nov 11. Lancet. 2019. PMID: 31727409 Clinical Trial.
Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial.
Negishi T, Thavendiranathan P, Penicka M, Lemieux J, Murbraech K, Miyazaki S, Shirazi M, Santoro C, Cho GY, Popescu BA, Kosmala W, Costello B, la Gerche A, Mottram P, Thomas L, Seldrum S, Hristova K, Bansal M, Kurosawa K, Fukuda N, Yamada H, Izumo M, Tajiri K, Sinski M, Vinereanu D, Shkolnik E, Banchs J, Kutty S, Negishi K, Marwick TH. Negishi T, et al. Among authors: bansal m. JACC Cardiovasc Imaging. 2023 Mar;16(3):269-278. doi: 10.1016/j.jcmg.2022.10.010. Epub 2022 Nov 16. JACC Cardiovasc Imaging. 2023. PMID: 36435732 Free article. Clinical Trial.
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.
Harrison SA, Abdelmalek MF, Neff G, Gunn N, Guy CD, Alkhouri N, Bashir MR, Freilich B, Kohli A, Khazanchi A, Sheikh MY, Leibowitz M, Rinella ME, Siddiqui MS, Kipnes M, Moussa SE, Younes ZH, Bansal M, Baum SJ, Borg B, Ruane PJ, Thuluvath PJ, Gottwald M, Khan M, Chen C, Melchor-Khan L, Chang W, DePaoli AM, Ling L, Lieu HD. Harrison SA, et al. Among authors: bansal m. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):603-616. doi: 10.1016/S2468-1253(22)00017-6. Epub 2022 Mar 21. Lancet Gastroenterol Hepatol. 2022. PMID: 35325622 Clinical Trial.
Cirrhosis Quality Collaborative.
Volk ML, Clarke C, Asrani SK, Khaderi S, Bansal MB, Tapper EB, Ho C, Chung RT, Lake J, Lim N, Fortune BE, Kim R, Dronamraju D, Kanwal F. Volk ML, et al. Among authors: bansal mb. Clin Gastroenterol Hepatol. 2022 May;20(5):970-972. doi: 10.1016/j.cgh.2022.01.043. Epub 2022 Feb 2. Clin Gastroenterol Hepatol. 2022. PMID: 35123089 No abstract available.
Myocarditis post-COVID-19 vaccination.
Bansal M, Mehta A, Pandey M. Bansal M, et al. Postgrad Med J. 2023 Sep 21;99(1176):1076-1079. doi: 10.1093/postmj/qgad030. Postgrad Med J. 2023. PMID: 37334983
Advances in asthma genetics.
Bansal M, Garg M, Agrawal A. Bansal M, et al. Adv Genet. 2021;107:1-32. doi: 10.1016/bs.adgen.2020.11.001. Epub 2021 Feb 2. Adv Genet. 2021. PMID: 33641744 Review.
Cardiovascular disease and COVID-19.
Bansal M. Bansal M. Diabetes Metab Syndr. 2020 May-Jun;14(3):247-250. doi: 10.1016/j.dsx.2020.03.013. Epub 2020 Mar 25. Diabetes Metab Syndr. 2020. PMID: 32247212 Free PMC article. Review.
MYCN and Metabolic Reprogramming in Neuroblastoma.
Bansal M, Gupta A, Ding HF. Bansal M, et al. Cancers (Basel). 2022 Aug 25;14(17):4113. doi: 10.3390/cancers14174113. Cancers (Basel). 2022. PMID: 36077650 Free PMC article. Review.
1,206 results